Klavdianou, Kalliopi <br/><br/>
Decreased Serotonin Levels and Serotonin-Mediated Osteoblastic Inhibitory Signaling in Patients With Ankylosing Spondylitis.  [electronic resource] 

 -  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research  Mar 2016 
 - 630-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-4681 
<br/><br/><label>Standard No.: </label>10.1002/jbmr.2724  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antirheumatic Agents--pharmacology<br/>Arthritis, Rheumatoid--blood<br/>Biomarkers--metabolism<br/>Case-Control Studies<br/>Cell Line<br/>Cell Proliferation--drug effects<br/>Crohn Disease--pathology<br/>Cyclic AMP Response Element-Binding Protein--metabolism<br/>Demography<br/>Duodenum--drug effects<br/>Female<br/>Humans<br/>Inflammation--blood<br/>Male<br/>Middle Aged<br/>Osteoblasts--drug effects<br/>Phosphorylation--drug effects<br/>Serotonin--blood<br/>Signal Transduction<br/>Spondylitis, Ankylosing--blood<br/>Tryptophan Hydroxylase--metabolism<br/>Tumor Necrosis Factor-alpha